相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antagonism of Neuronal Prostaglandin E2 Receptor Subtype 1 Mitigates Amyloid β Neurotoxicity In Vitro
Xianwu Li et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2013)
Neuronal aggregates are associated with phenotypic onset in the R6/2 Huntington's disease transgenic mouse
Randi-Michelle Cowin et al.
BEHAVIOURAL BRAIN RESEARCH (2012)
Mutant huntingtin, abnormal mitochondrial dynamics, defective axonal transport of mitochondria, and selective synaptic degeneration in Huntington's disease
P. Hemachandra Reddy et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2012)
Comparative analysis of pathology and behavioural phenotypes in mouse models of Huntington's disease
Simon P. Brooks et al.
BRAIN RESEARCH BULLETIN (2012)
Long-term memory deficits in Huntingtons disease are associated with reduced CBP histone acetylase activity
A. Giralt et al.
HUMAN MOLECULAR GENETICS (2012)
Activation of Elk-1 participates as a neuroprotective compensatory mechanism in models of Huntington's disease
Marta Anglada-Huguet et al.
JOURNAL OF NEUROCHEMISTRY (2012)
PGE2 EP1 receptor exacerbated neurotoxicity in a mouse model of cerebral ischemia and Alzheimer's disease
Gehua Zhen et al.
NEUROBIOLOGY OF AGING (2012)
Increased PKA signaling disrupts recognition memory and spatial memory: role in Huntington's disease
Albert Giralt et al.
HUMAN MOLECULAR GENETICS (2011)
Huntington's disease: from molecular pathogenesis to clinical treatment
Christopher A. Ross et al.
LANCET NEUROLOGY (2011)
Conditional BDNF release under pathological conditions improves Huntington's disease pathology by delaying neuronal dysfunction
Albert Giralt et al.
MOLECULAR NEURODEGENERATION (2011)
Dantrolene is neuroprotective in Huntington's disease transgenic mouse model
Xi Chen et al.
MOLECULAR NEURODEGENERATION (2011)
PATHOPHYSIOLOGY OF HUNTINGTON'S DISEASE: TIME-DEPENDENT ALTERATIONS IN SYNAPTIC AND RECEPTOR FUNCTION
L. A. Raymond et al.
NEUROSCIENCE (2011)
BDNF regulation under GFAP promoter provides engineered astrocytes as a new approach for long-term protection in Huntington's disease
A. Giralt et al.
GENE THERAPY (2010)
Prostaglandin E2-Induced Synaptic Plasticity in Neocortical Networks of Organotypic Slice Cultures
Henner Koch et al.
JOURNAL OF NEUROSCIENCE (2010)
Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington's disease
Robert Schwarcz et al.
PROGRESS IN NEUROBIOLOGY (2010)
Emerging roles of PGE2 receptors in models of neurological disease
Katrin Andreasson
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2010)
Inhibition of Rho Kinases Enhances the Degradation of Mutant Huntingtin
Peter O. Bauer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Altered hippocampal long-term synaptic plasticity in mice deficient in the PGE2 EP2 receptor
Hongwei Yang et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Reduced calcineurin protein levels and activity in exon-1 mouse models of Huntington's disease: Role in excitotoxicity
Xavier Xifro et al.
NEUROBIOLOGY OF DISEASE (2009)
BRAIN-DERIVED NEUROTROPHIC FACTOR MODULATES THE SEVERITY OF COGNITIVE ALTERATIONS INDUCED BY MUTANT huntingtin: INVOLVEMENT OF PHOSPHOLIPASECγ ACTIVITY AND GLUTAMATE RECEPTOR EXPRESSION
A. Giralt et al.
NEUROSCIENCE (2009)
Cyclooxygenase-2 inhibition improves amyloid-β-mediated suppression of memory and synaptic plasticity
Linda A. Kotilinek et al.
BRAIN (2008)
Calcium ions in neuronal degeneration
Urszula Wojda et al.
IUBMB LIFE (2008)
Dopaminergic and glutamatergic signaling crosstalk in Huntington's disease neurodegeneration:: The role of p25/cyclin-dependent kinase 5
Paola Paoletti et al.
JOURNAL OF NEUROSCIENCE (2008)
Gene-environment interactions modulating cognitive function and molecular correlates of synaptic plasticity in Huntington's disease transgenic mice
Jess Nithianantharajah et al.
NEUROBIOLOGY OF DISEASE (2008)
Disruption of striatal glutamatergic transmission induced by mutant huntingtin involves remodeling of both postsynaptic density and NMDA receptor signaling
Jess F. Torres-Peraza et al.
NEUROBIOLOGY OF DISEASE (2008)
Prostaglandin E2 acts on EP1 receptor and amplifies both dopamine D1 and D2 receptor signaling in the striatum
Shiho Kitaoka et al.
JOURNAL OF NEUROSCIENCE (2007)
Prostaglandin E2 enhances mitogen-activated protein kinase/Erk pathway in human cholangiocarcinoma cells:: involvement of EP1 receptor, calcium and EGF receptors signaling
Li Zhang et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2007)
PGE2 receptor EP1 renders dopaminergic neurons selectively vulnerable to low-level oxidative stress and direct PGE2 neurotoxicity
Emilce Carrasco et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2007)
Dopaminergic signaling and striatal neurodegeneration in Huntington's disease
Tie-Shan Tang et al.
JOURNAL OF NEUROSCIENCE (2007)
Contributions of cyclooxygenase-2 to neuroplasticity and neuropathology of the central nervous system
Sandra J. Hewett et al.
PHARMACOLOGY & THERAPEUTICS (2006)
Early development of aberrant synaptic plasticity in a mouse model of Huntington's disease
AJ Milnerwood et al.
HUMAN MOLECULAR GENETICS (2006)
Prostaglandin E2 EP1 receptors:: downstream effectors of COX-2 neurotoxicity
T Kawano et al.
NATURE MEDICINE (2006)
Prostaglandin EP1 receptor contributes to excitotoxicity and focal ischemic brain damage
AS Ahmad et al.
TOXICOLOGICAL SCIENCES (2006)
Prostaglandin EN receptor agonist protects against acute neurotoxicity
AS Ahmad et al.
BRAIN RESEARCH (2005)
Stabilizing effects of extracellular ATP on synaptic efficacy and plasticity in hippocampal pyramidal neurons
ED Martín et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Regulation of proteins affecting NMDA receptor-induced excitotoxicity in a Huntington's mouse model
BR Jarabek et al.
BRAIN (2004)
Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia
L McCullough et al.
JOURNAL OF NEUROSCIENCE (2004)
Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease
JM Canals et al.
JOURNAL OF NEUROSCIENCE (2004)
PGE2 receptors rescue motor neurons in a model of amyotrophic lateral sclerosis
M Bilak et al.
ANNALS OF NEUROLOGY (2004)
Cognitive changes in patients with Huntington's disease (HD) and asymptomatic carriers of the HD mutation - A longitudinal follow-up study
J Lemiere et al.
JOURNAL OF NEUROLOGY (2004)
Huntington's disease: a synaptopathy?
JY Li et al.
TRENDS IN MOLECULAR MEDICINE (2003)
Evidence for more widespread cerebral pathology in early HD - An MRI-based morphometric analysis
HD Rosas et al.
NEUROLOGY (2003)
Complex alteration of NMDA receptors in transgenic Huntington's disease mouse brain: analysis of mRNA and protein expression, plasma membrane association, interacting proteins, and phosphorylation
R Luthi-Carter et al.
NEUROBIOLOGY OF DISEASE (2003)
Resistance to NMDA toxicity correlates with appearance of nuclear inclusions, behavioural deficits and changes in calcium homeostasis in mice transgenic for exon 1 of the huntington gene
O Hansson et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2001)
Prostanoid receptors: Subtypes and signaling
RM Breyer et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2001)
Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease
A Yamamoto et al.
CELL (2000)
分享论文
